Nation’s Independent Long Term Care Pharmacies Commend Administration for Nomination of Alex Azar II for Secretary of the U.S. Department of Health and Human Services (HHS)
Washington, DC – The Senior Care Pharmacy Coalition (SCPC) – the leading non-profit advocacy organization dedicated to representing the exclusive legislative and regulatory interests of independent long term care (LTC) pharmacies and the vulnerable patients they serve – today commended President Trump for his nomination of Alex Azar for Secretary of the Department of Health and Human Services (HHS).
SCPC pointed to Azar’s deep understanding of the healthcare sector and experience from both the private and public side of the industry, including the Medicare and Medicaid programs that are so essential to the millions of seniors and vulnerable Americans who rely upon them for their care. Mr. Azar’s experience is crucial to striking a balance to protect and improve the integrity of the nation’s healthcare system.
“Mr. Azar has a reputation for data-driven, bipartisan policy solutions that improve patient care and safety, while improving efficiencies, such as the reduction of hospital admissions,” said Alan Rosenbloom, CEO of SCPC. “SCPC remains supportive of and hopeful for an expeditious confirmation so we may work collaboratively to address important issues ranging from improving patient care to reducing the financial burdens on seniors and our healthcare system. To do so, we look forward to working with Mr. Azar to uncover and eliminate the oligopolistic and ant-competitive pricing and market practices of secretive Pharmacy Benefit Managers (PBMs), which are putting patient care at risk and driving up prescription drug costs to consumers and the Medicare program.”
####
The SCPC is the national association for independent LTC pharmacies. Our member pharmacies provide care and services to patients in LTC facilities across the country occupying approximately 675,000 beds. Visit us at www.seniorcarepharmacies.org to learn more.
Recent Posts
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
-
60 percent of LTC pharmacies warn of closure amid major drug pricing changes
Facing deep losses on high-demand medications, 85% of long-term care pharmacies say they will limit essential services and 60% will close locations without changes to Medicare drug pricing efforts. Those are among the “unintended consequences” revealed in a Senior Care Pharmacy Coalition survey released Wednesday. The trade association has been increasingly vocal about pricing changes set to go into effect in January.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.